Prestige Consumer Healthcare Inc 's Revenue in the fiscal year 2026 $ 1,088.58 millions
Prestige Consumer Healthcare Inc 's Revenue in the fiscal year 2025 $ 1,137.46 millions
Prestige Consumer Healthcare Inc 's Revenue in the fiscal year 2024 $ 1,124.45 millions
Prestige Consumer Healthcare Inc 's Revenue in the fiscal year 2023 $ 1,127.73 millions
Prestige Consumer Healthcare Inc 's Revenue in the fiscal year 2022 $ 1,086.81 millions
PBH Revenue second quarter 2027 Y/Y Growth Comment
Prestige Consumer Healthcare Inc achieved in the second quarter 2027, above Company average Revenue growth of 22.93% year on year, to $ 336.31 millions.
Looking into second quarter 2027 results within Major Pharmaceutical Preparations industry 114 other companies have achieved higher Revenue growth. While Prestige Consumer Healthcare Inc ' s Revenue rise of 22.93% ranks overall at the positon no. 2129 in the second quarter 2027.
Prestige Consumer Healthcare Inc achieved in the II. Quarter 2027 above company average sequential Revenue jump of 26.57%, to $ 336.31 millions, from $265.71 millions in the first quarter. PBH is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 110 other companies have achieved higher Revenue quarter on quarter growth. While Prestige Consumer Healthcare Inc 's Revenue growth quarter on quarter, overall rank is 2592.
Prestige Consumer Healthcare Inc achieved in the II. Quarter 2027 above company average sequential Revenue jump of 26.57%, to $ 336.31 millions, from $265.71 millions in the first quarter. PBH is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 110 other companies have achieved higher Revenue quarter on quarter growth. While Prestige Consumer Healthcare Inc 's Revenue growth quarter on quarter, overall rank is 2592.
Prestige Consumer Healthcare Inc 's 12 Months Revenue Growth Year on Year
Prestige Consumer Healthcare Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Prestige Consumer Healthcare Inc 's annual Revenue improvement would be -1.32% year on year to $1,105 millions.
In the Healthcare sector 371 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2057 to 2545.
Prestige Consumer Healthcare Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Prestige Consumer Healthcare Inc 's annual Revenue decrease would be -1.32% year on year to $1,105 millions.
In the Healthcare sector 371 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2057 to 2545.
About Prestige Consumer Healthcare Inc Revenue Growth Rates (PBH), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
40.00%